Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast cancer confirmed by a tissue sample (biopsy)
- People who have evidence of cancer that has spread (metastasised) to other parts of the body, confirmed by a tissue sample and/or medical imaging
- People whose cancer spread occurred within 10 years of when the registry began
- People who have given signed consent to participate (if a person has already passed away at the time of entry into the registry, their data may be entered without a consent form)
Who may not be able to join:
- Because this is an observational registry rather than an active treatment trial, the trial site has stated that there are no specific exclusion criteria
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Greil, MD, AGMT gemeinnützige GmbH
Phone: +43 662 6404412
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with prognostic factors for metastatic breast cancer; Number of patients according to molecular subtypes; Frequency and tumour characteristics of breast cancer in male patients; Overall survival of patients with metastatic breast cancer in Austria
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.